PPT-ADNI Genetics Core Update

Author : pamella-moone | Published Date : 2018-02-02

Andy Saykin WWADNI Meeting London UK July 14 2017 asaykiniupuiedu Overview and 2017 Updates ADNI3 sample collection banked at NCRAD Longitudinal DNA amp RNA 12 new

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "ADNI Genetics Core Update" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

ADNI Genetics Core Update: Transcript

Andy Saykin WWADNI Meeting London UK July 14 2017 asaykiniupuiedu Overview and 2017 Updates ADNI3 sample collection banked at NCRAD Longitudinal DNA amp RNA 12 new 79 continuing Changes in ADNI3 include PBMC and RBC collection. Leslie M Shaw & John Q . Trojanowski. Magdalena Korecka. Michal Figurski. Teresa . Waligorska. Magdalena Brylska. Leona Fields. Nirali. Shah. Biomarker Core Aims for ADNI 3. Continue to collect, store, curate and track all . . Arg. -ADNI. Gustavo E. Sevlever . , Ricardo . F. . Allegri (. *. ), . Silvia Vázquez, Deborah R. . Gustafson. , . Salvador M. Guinjoan, . and Arg-ADNI group.. Memory and Aging Center. Institute for Neurological Research . AAIC 2017. Presenter: Dr. Patricio . Chrem. . On . Behalf of:. Dr. Prof Ricardo Allegri (PI) . Dr. Gustavo Sevlever. July 14. th. , 2017. Arg. -ADNI. Patients’ Flowchart. Patients Screened at FLENI. Update. Veronika. . Logovinsky. , MD, PhD. . 2017 . Chairperson . WW ADNI Meeting. July . 14, 2017. PPSB: Leadership. Chair. N/A. Chair-elect. Veronika . Logovinsky. , Eisai. FNIH. Michael Biarnes, Scientific Project Manager* . Initiative . December, 2010. NEED FOR VALIDATED BIOMARKERS FOR AD TRIALS. Biomarkers useful in Phase 2 to make decisions about Phase 3 (e.g. doses). Biomarkers useful in Phase 3. Provide additional evidence to support primary outcome findings. Update. James Hendrix. , PhD. 2018 Chairperson . WW ADNI Meeting. July 20, 2018. PPSB: Leadership. Chair. James Hendrix, Alzheimer’s Association . Chair-elect. Aparna . Vasanthakumar. , AbbVie . FNIH. Leslie M Shaw and John Q Trojanowski. WW ADNI meeting. Chicago, July 20, 2018. CSF. Ser. + . Pla. TOTAL. ADNI 1 Primary . Biofluids. Collected. 1118. 9756. 10874. ADNI . 1 Aliquots in Bank. 24934. Boston, MA 4/24/2017 . Leslie M Shaw. John Q Trojanowski. New biomarkers in NIA/ADNI/RARC-approved studies . Biomarker. Fluid. #. ADNI study. Investigator. NFL & Tau . diag. /prognosis. Plasma. 3,000+. Worldwide-ADNI Update Meeting. Friday, July 22, 2016. Fairmont Royal York . Hotel. Toronto. Andy Saykin, . Indiana University. For the Genetics Core/Working Groups. asaykin@iupui.edu. Genetics Core Goals for ADNI-3. WW-ADNI Meeting, Washington DC. July 17, 2015. Andy Saykin, . Indiana University. asaykin@iupui.edu. For the Genetics Core/Working Groups. Original ADNI-2 Specific Aims. Progress Report & Impact. Silvia Vázquez, Deborah R. . Gustafson. , . Salvador M. Guinjoan, . Ricardo F. Allegri. and . Arg. -ADNI . group. .. Memory and Aging Center. Institute for Neurological Research . (FLENI. ) . Buenos Aires, Argentina. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward . Funded MRI Investigators. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward . Funded MRI Investigators. Cliff Jack. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward .

Download Document

Here is the link to download the presentation.
"ADNI Genetics Core Update"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.